Vanguard Group Inc 13D/13G Filings for Aldeyra Therapeutics, Inc. (ALDX)

Vanguard Group Inc 13D and 13G filings for Aldeyra Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-13
4:58 pm
Purchase
2023-12-2913GAldeyra Therapeutics, Inc.
ALDX
Vanguard Group Inc3,927,597
6.680%
3,927,597increase
(New Position)
Filing